Want to see HK:3860 full AI Analyst Report?
3860 Stock Chart & Stats
HK$0.63
HK$0.04(8.00%)
At close: 4:00 PM EST
HK$0.63
HK$0.04(8.00%)
Day’s Range― - ―
52-Week RangeHK$0.44 - HK$0.84
Previous CloseN/A
Volume120.00K
Average Volume (3M)60.17K
Market Cap
HK$343.63M
Enterprise ValueHK$189.00M
Total Cash (Recent Filing)HK$130.49M
Total Debt (Recent Filing)HK$4.45M
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Dec 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.69%
Share Statistics
EPS (TTM)-0.03
Shares Outstanding582,429,800
10 Day Avg. Volume59,510
30 Day Avg. Volume60,170
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)2.71
Price to Sales (P/S)0.63
P/FCF Ratio11.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strengthened Balance SheetMaterial deleveraging and a low debt-to-equity position enhance financial flexibility over the medium term. This reduces default and refinancing risk, supports investment or restructuring options, and gives management latitude to deploy capital into growth, working capital, or opportunistic M&A.
Positive Operating And Free Cash FlowA shift to positive operating and free cash flow signals improved cash conversion capacity, which sustainably supports internal funding for inventory, capex, and shareholder returns. If maintained, this strengthens liquidity and reduces dependence on external financing across business cycles.
Demonstrated Ability To Be ProfitableThe company’s 2025 performance shows the business model can deliver healthy margins and profitable operations under favorable conditions. This indicates operational levers and market positioning that can be reactivated, supporting medium-term recovery potential if management sustains execution.
Bears Say
Volatile Revenue TrajectoryWide revenue swings undermine predictability of cash flows and margin planning. Persistent top-line volatility suggests exposure to cyclical demand, inventory or distribution risks, and weak recurring revenue, making multi-quarter planning and stable margins harder to sustain for management.
Earnings Instability And Return To Net LossReverting from profit to net loss within one year highlights earnings fragility and operational sensitivity to cost or revenue shifts. Such swings compress retained earnings, produce ROE volatility, and complicate capital allocation decisions, increasing execution risk over the medium term.
Cash Flow Inconsistency Vs EarningsHighly volatile free cash flow and discrepancies between cash and reported earnings weaken the reliability of internal funding. This unpredictability hampers sustainable dividend, capex, or inventory strategies and raises the chance management must seek external financing during downturns.
EPS Creative Health Technology Group Limited News
3860 FAQ
What was EPS Creative Health Technology Group Limited’s price range in the past 12 months?
EPS Creative Health Technology Group Limited lowest stock price was HK$0.43 and its highest was HK$0.84 in the past 12 months.
What is EPS Creative Health Technology Group Limited’s market cap?
EPS Creative Health Technology Group Limited’s market cap is HK$343.63M.
When is EPS Creative Health Technology Group Limited’s upcoming earnings report date?
EPS Creative Health Technology Group Limited’s upcoming earnings report date is Dec 02, 2026 which is in 116 days.
How were EPS Creative Health Technology Group Limited’s earnings last quarter?
EPS Creative Health Technology Group Limited released its earnings results on Jun 29, 2026. The company reported -HK$0.019 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.019.
Is EPS Creative Health Technology Group Limited overvalued?
According to Wall Street analysts EPS Creative Health Technology Group Limited’s price is currently Overvalued.
Does EPS Creative Health Technology Group Limited pay dividends?
EPS Creative Health Technology Group Limited pays a Annually dividend of HK$0.01 which represents an annual dividend yield of 1.69%. See more information on EPS Creative Health Technology Group Limited dividends here
What is EPS Creative Health Technology Group Limited’s EPS estimate?
EPS Creative Health Technology Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EPS Creative Health Technology Group Limited have?
EPS Creative Health Technology Group Limited has 582,429,800 shares outstanding.
What happened to EPS Creative Health Technology Group Limited’s price movement after its last earnings report?
EPS Creative Health Technology Group Limited reported an EPS of -HK$0.019 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of EPS Creative Health Technology Group Limited?
Currently, no hedge funds are holding shares in HK:3860
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EPS Creative Health Technology Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-15.81%
12-Months-Change
Fundamentals
Return on Equity
1.69%
Trailing 12-Months
Asset Growth
-7.56%
Trailing 12-Months
Company Description
EPS Creative Health Technology Group Limited
EPS Creative Health Technology Group Limited functions as an investment holding company with diverse operations. It specializes in comprehensive apparel supply chain management, serving clients across Hong Kong, mainland China, Japan, the United States, Europe, and other global markets. The company's activities are divided into two main segments: Garment and Healthcare. Within its Garment division, EPS Creative Health delivers end-to-end supply chain solutions for various knitwear products, including women's, men's, and children's apparel. These services encompass everything from initial fashion trend analysis and product conceptualization to material sourcing, meticulous production oversight, stringent quality control, and efficient logistics. Its clientele primarily comprises owners and sourcing agents of apparel retail brands. Concurrently, the Healthcare segment focuses on the development of novel pharmaceuticals, offers innovative research organization (IRO) services, and provides expert medical consultancy. The group also handles general client account management and related support services. Established in 1999 and headquartered in Hung Hom, Hong Kong, the company was formerly known as Speed Apparel Holding Limited before officially adopting its current name in August 2021. EPS Creative Health Technology Group Limited operates as a subsidiary of EPS Holdings, Inc.
Technical Analysis
Giordano International
―
Xtep International Holdings
―
EEKA Fashion Holdings Limited
―
Topsports International Holdings Limited
―
Fast Retailing Co Ltd Shs Unsponsored Hong Kong Depositary Receipt Repr 1/100th Sh
―